The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
Open Access
- 29 June 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 18 (6), e1010592
- https://doi.org/10.1371/journal.ppat.1010592
Abstract
Exposure histories to SARS-CoV-2 variants and vaccinations will shape the specificity of antibody responses. To understand the specificity of Delta-elicited antibody immunity, we characterize the polyclonal antibody response elicited by primary or mRNA vaccine-breakthrough Delta infections. Both types of infection elicit a neutralizing antibody response focused heavily on the receptor-binding domain (RBD). We use deep mutational scanning to show that mutations to the RBD’s class 1 and class 2 epitopes, including sites 417, 478, and 484–486 often reduce binding of these Delta-elicited antibodies. The anti-Delta antibody response is more similar to that elicited by early 2020 viruses than the Beta variant, with mutations to the class 1 and 2, but not class 3 epitopes, having the largest effects on polyclonal antibody binding. In addition, mutations to the class 1 epitope (e.g., K417N) tend to have larger effects on antibody binding and neutralization in the Delta spike than in the D614G spike, both for vaccine- and Delta-infection-elicited antibodies. These results help elucidate how the antigenic impacts of SARS-CoV-2 mutations depend on exposure history. SARS-CoV-2 has been circulating among humans for over two years, and immune selection has become a major driver of its evolution. In addition to partially evading the immune response elicited by vaccination or infection with earlier variants, SARS-CoV-2 “variants of concern” can also elicit distinct antibody responses. Here, we use the high-throughput techniques of deep mutational scanning and yeast display to characterize the antibody response elicited by primary or vaccine-breakthrough infections with the Delta variant. We compare these responses to those elicited by mRNA vaccination, infection with early 2020 viruses, or infection the Beta variant. We find that the early 2020 and Delta-elicited antibody responses often target similar regions of the spike receptor-binding domain, with some subtle but notable differences. The antibody response to Delta and early 2020 strains are more similar to each other than to the Beta variant. As SARS-CoV-2 continues to evolve, individuals’ increasingly diverse exposure histories to vaccines and variants will influence their susceptibilities to future viral mutations.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (HHSN272201400006C)
- National Institute of Allergy and Infectious Diseases (75N93021C00015)
- National Institute of Allergy and Infectious Diseases (R01AI141707)
- National Institute of Allergy and Infectious Diseases (T32AI083203)
- National Institute of Allergy and Infectious Diseases (R01AI138546)
- Bill and Melinda Gates Foundation (INV-004949)
- Bill and Melinda Gates Foundation (INV-016575)
- Bill and Melinda Gates Foundation (INV-018944)
- National Institutes of Health (S10OD028685)
- Damon Runyon Cancer Research Foundation (DRG-2381-19)
- Howard Hughes Medical Institute
- Emergent Ventures Award
- Benaryoa Family Foundation
- Leonard and Norma Klorfine Foundation
- Glenn and Mary Lynn Mounger
- Monolithic Power Systems
This publication has 62 references indexed in Scilit:
- dms-view: Interactive visualization tool for deep mutational scanning dataThe Journal of Open Source Software, 2020
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Science, 2020
- SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effectsNature Structural & Molecular Biology, 2020
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization AssaysViruses, 2020
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorNature, 2020
- alignparse: A Python package for parsing complex features from high-throughput long-read sequencingThe Journal of Open Source Software, 2019
- Data, disease and diplomacy: GISAID's innovative contribution to global healthGlobal Challenges, 2017
- A Novel High-Throughput Screen Reveals Yeast Genes That Increase Secretion of Heterologous ProteinsApplied and Environmental Microbiology, 2007
- Large-scale high-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG methodNature Protocols, 2007